Tag:

Booster Shots

COVID-19: Hospitalizations, Positive Infection Rate Down In CT; Latest Breakdown Of Data COVID-19: Hospitalizations, Positive Infection Rate Down In CT; Latest Breakdown Of Data
Covid-19: Hospitalizations, Positive Infection Rate Down In CT; Latest Breakdown Of Data The positive COVID-19 infection rate and hospitalizations are both down in Connecticut as the state recovers from the most recent wave of new cases. On Thursday, March 31, nearly 14,000 COVID-19 tests were administered in Connecticut, resulting in 501 confirmed new cases for a 3.68 percent daily positive infection rate, down slightly from the numbers recorded earlier in the week. Seven more COVID-19 patients were discharged from Connecticut hospitals, bringing the total being treated down to 81 after topping 100 for several days last week. As of Friday, April 1, more than 3 million Connect…
COVID-19: Positivity Rate Rises To Near 4 Percent In CT, 32 New Deaths Reported COVID-19: Positivity Rate Rises To Near 4 Percent In CT, 32 New Deaths Reported
Covid-19: Positivity Rate Rises To Near 4 Percent In CT, 32 New Deaths Reported The positive COVID-19 infection rate continues to rise in Connecticut, which reported nearly three dozen new deaths. In its latest update on Thursday, March 31, the state Department of Public Health reported 32 new virus-related deaths in the past week, as the number of deaths rose to 10,776 since March 2020. On Wednesday, March 30, nearly 12,000 COVID-19 tests were administered in Connecticut, resulting in 471 confirmed new cases for a 3.95 percent daily positive infection rate after seeing it hover around 2 percent for weeks earlier in 2022. Ten more COVID-19 patients were discharged fro…
COVID-19: Hospitalizations Back Below 100 In CT; Latest Breakdown Of Cases, Deaths By County COVID-19: Hospitalizations Back Below 100 In CT; Latest Breakdown Of Cases, Deaths By County
Covid-19: Hospitalizations Back Below 100 In CT; Latest Breakdown Of Cases, Deaths By County The number of COVID-19 patients being treated in Connecticut hospitals is back below 100 as the state continues its recovery from the winter surge of infections across the state. On Tuesday, March 29, there were nearly 14,000 COVID-19 tests administered in Connecticut, according to the latest update from the state Department of Public Health, which resulted in 458 confirmed cases of the virus for a 3.35 percent daily positive infection rate, down slightly from the previous day. Three COVID-19 patients were discharged from Connecticut hospitals, bringing the total to 98 still being treated f…
COVID-19: Infection Rate Near 4 Percent, Hospitalizations Up In CT; Latest Breakdown Of Cases COVID-19: Infection Rate Near 4 Percent, Hospitalizations Up In CT; Latest Breakdown Of Cases
Covid-19: Infection Rate Near 4 Percent, Hospitalizations Up In CT; Latest Breakdown Of Cases After seeing the COVID-19 numbers in Connecticut showing improvement for several weeks, the positive infection rate and virus-related hospitalizations are back on the rise. On Monday, March 28, the Connecticut Department of Public Health reported that out of more than 10,000 COVID-19 tests that were administered statewide, there were 365 laboratory-confirmed infections for a 3.65 percent daily positive rate, up from the weekend. Seven more COVID-19 patients were also admitted to Connecticut hospitals, bringing the total being treated for the virus back above 100 to 101.  Of the 101 CO…
COVID-19: Positivity Rate Below 2.5 Percent In CT, 62 New Deaths Reported COVID-19: Positivity Rate Below 2.5 Percent In CT, 62 New Deaths Reported
Covid-19: Positivity Rate Below 2.5 Percent In CT, 62 New Deaths Reported The daily COVID-19 positivity rate in Connecticut dipped back under 2.5 percent for the second straight day as the death toll approaches 10,700 since the pandemic began more than two years ago. On Wednesday, March 16, nearly 17,000 COVID-19 tests were administered in Connecticut, resulting in 404 confirmed new cases for a 2.40 percent daily positive infection rate. Sixty-two new COVID-19 fatalities were reported in the past week in Connecticut, bringing the death toll to 10,677 since the outset of the pandemic in March 2020. Two more COVID-19 patients were admitted to Connecticut hospitals…
COVID-19: Hospitalizations Down, Positivity Up In CT; Latest Breakdown Of Cases, Deaths COVID-19: Hospitalizations Down, Positivity Up In CT; Latest Breakdown Of Cases, Deaths
Covid-19: Hospitalizations Down, Positivity Up In CT; Latest Breakdown Of Cases, Deaths The number of COVID-19 patients being treated in Connecticut hospitals is approaching double digits for the first time since last summer, though the positive infection rate statewide rose for the third straight day. There were nearly 11,000 COVID-19 tests administered in Connecticut on Monday, March 14, according to the latest update from the state Department of Health, resulting in 305 confirmed cases of the virus for a 2.88 daily positive infection rate. The infection rate is up from 2.57 the previous day and below 2 percent last week. Eight more COVID-19 patients were discharged from Co…
COVID-19: Infection Rate Below 3 Percent In CT; Latest Breakdown Of Cases, Deaths By County COVID-19: Infection Rate Below 3 Percent In CT; Latest Breakdown Of Cases, Deaths By County
Covid-19: Infection Rate Below 3 Percent In CT; Latest Breakdown Of Cases, Deaths By County The daily COVID-19 positivity rate in Connecticut continues to plummet, down below 3 percent, according to the latest update from the state Department of Public Health. On Thursday, Feb. 24, there were 16,591 COVID-19 tests administered in Connecticut which resulted in 423 confirmed cases of the virus for a 2.55 percent daily positivity rate, among the lowest recorded in 2022. Thirteen more COVID-19 patients being treated in Connecticut hospitals were discharged, leaving 235 still hospitalized with the virus. Of those patients, 113 (48.1 percent) were not fully vaccinated, officials noted. …
COVID-19: CDC Expected To Greatly Ease Indoor Mask Guidance, Reports Say COVID-19: CDC Expected To Greatly Ease Indoor Mask Guidance, Reports Say
Covid-19: CDC Expected To Greatly Ease Indoor Mask Guidance, Reports Say The US Centers for Disease Control and Prevention (CDC) is expected to significantly ease its indoor mask mandate as the country continues its recovery from the latest wave of COVID-19 infections. According to multiple reports, the CDC is expected to announce a change in its guidance regarding masks, allowing most Americans to ditch their facial coverings indoors. The AP first reported the news, citing “two people familiar with the matter.” The new guidance is expected to be announced as soon as Friday, Feb. 25. It marks the first indoor mask guidance change from the CDC since July 2021. …
COVID-19: Infection Rate Above 3.5 Percent In CT; Latest Breakdown Of Cases, Deaths COVID-19: Infection Rate Above 3.5 Percent In CT; Latest Breakdown Of Cases, Deaths
Covid-19: Infection Rate Above 3.5 Percent In CT; Latest Breakdown Of Cases, Deaths The daily COVID-19 positivity rate in Connecticut rose back above 3.50 percent as the number of patients being hospitalized for the virus held steady at 261 for the second straight day. According to the latest update from the Connecticut Department of Public Health, there were 9,618 COVID-19 tests administered statewide on Monday, Feb. 21, resulting in 338 confirmed positive cases, resulting in a 3.51 percent daily infection rate, up from below 3 percent over the weekend. Of the 261 COVID-19 patients being treated in Connecticut hospitals, health officials noted that 128 (49 percent) are no…
COVID-19: Positivity Rate Steady In CT, 105 New Deaths Reported; Latest Breakdown Of Cases COVID-19: Positivity Rate Steady In CT, 105 New Deaths Reported; Latest Breakdown Of Cases
Covid-19: Positivity Rate Steady In CT, 105 New Deaths Reported; Latest Breakdown Of Cases The daily COVID-19 positivity rate in Connecticut held steady under 5 percent as the death toll in the state topped 10,300 since the beginning of the pandemic. On Wednesday, Feb. 16, 11,542 COVID-19 tests were administered in Connecticut, resulting in 544 confirmed new cases for a 4.71 percent positive infection rate, up slightly from the previous day. In January, the infection rate hovered above 20 percent for several weeks, peaking in the middle of the month. One hundred and five new COVID-19 fatalities in the past week in Connecticut brought the death toll to 10,324 since March 2020. F…
COVID-19: Hospitalizations, Infection Rate Down In CT; Latest Rundown Of Cases, Deaths COVID-19: Hospitalizations, Infection Rate Down In CT; Latest Rundown Of Cases, Deaths
Covid-19: Hospitalizations, Infection Rate Down In CT; Latest Rundown Of Cases, Deaths The daily COVID-19 positive infection rate in Connecticut is back near 5 percent as the number of patients being treated for the virus dipped under 600 statewide. On Tuesday, Feb. 8, there were 20,325 COVID-19 tests administered in Connecticut, resulting in 1,048 confirmed cases of the virus for a 5.16 percent daily positivity, down nearly 2 percent from the previous day. Fifty-five more COVID-19 patients were discharged from Connecticut hospitals, as the number being treated for the virus dipped to 552 statewide. Of the 552 COVID-19 patients, officials noted that less than half (272) were…
COVID-19: Hospitalizations Back Below 1,700 In CT; Latest Breakdown Of Cases, Deaths, By County COVID-19: Hospitalizations Back Below 1,700 In CT; Latest Breakdown Of Cases, Deaths, By County
Covid-19: Hospitalizations Back Below 1,700 In CT; Latest Breakdown Of Cases, Deaths, By County The number of patients being treated for COVID-19 in Connecticut hospitals has dipped below 1,700 as the state continues to see a strong recovery following a post-holiday surge of new infections over the past month. In the latest update from the State Department of Public Health on Friday, Jan. 21, there were 32,459 COVID-19 tests administered the previous day, resulting in 4,444 laboratory-confirmed cases for a 13.69 percent daily positive infection rate, continuing a trend of cases declining. After plateauing near 25 percent for several days last week, the daily positivity rate has been p…
COVID-19: Here's When Fourth Shot May Be Needed, Moderna CEO Says COVID-19: Here's When Fourth Shot May Be Needed, Moderna CEO Says
Covid-19: Here's When Fourth Shot May Be Needed, Moderna CEO Says The chief executive officer of Moderna has gone on record saying when another round of COVID-19 vaccine booster shots could be required. Moderna CEO Stephane Bancel said this week that due to the efficacy of the vaccine potentially waning over time, a fourth booster could be required before the fall of 2022. Bancel made the proclamation at a Goldman-Sachs-organized healthcare conference, noting that his company is working on a booster shot dedicated to combating the Omicron variant of the virus, which will likely be made available within the next two months. According to recent studies, bo…
COVID-19: CDC Shortens Waiting Period For Pfizer Booster Shots COVID-19: CDC Shortens Waiting Period For Pfizer Booster Shots
Covid-19: CDC Shortens Waiting Period For Pfizer Booster Shots Americans who received the Pfizer and BioNTech COVID-19 vaccine can now get a booster shot in a shorter timeframe than originally recommended, according to federal health officials who passed a pair of measures to make the vaccine more readily available. The US Centers for Disease Control and Prevention (CDC) announced on Tuesday, Jan. 4 that booster shots should be made available five months after receiving the second dose of the vaccine, down from the original recommendation of at least six months. Those who received the Moderna vaccine must still wait at least six months after their seco…
COVID-19: Info Released On First US Omicron Death; Biden To Announce 500M Free At-Home Tests COVID-19: Info Released On First US Omicron Death; Biden To Announce 500M Free At-Home Tests
Covid-19: Info Released On First US Omicron Death; Biden To Announce 500M Free At-Home Tests Less than three weeks after the first case of the highly transmissible Omicron COVID-19 variant was identified in the United States, the first death in the nation connected to the strain has been confirmed in the Houston, Texas area. The patient was a man in his 50s who was not vaccinated and had an underlying health condition, Harris County Judge Lina Hidalgo said, according to KHOU-11, a CBS-affiliated television station in Houston. Houston Methodist said on Monday, Dec. 20 that 82 percent of its new cases are omicron after just three weeks of testing for it, KHOU reported. Omicron …
COVID-19: First Findings Released On Vaccine Effectiveness Against Omicron Variant COVID-19: First Findings Released On Vaccine Effectiveness Against Omicron Variant
Covid-19: First Findings Released On Vaccine Effectiveness Against Omicron Variant The first findings on the effectiveness of vaccines against the COVID-19 Omicron variant have been released. Pfizer and its European partner BioNTech said that a booster shot offers significant protection against Omicron and "neutralizes" the strain. Two vaccine doses "show significantly reduced neutralization titers" but could protect against severe disease from COVID, the companies said. The findings come from an initial laboratory study. According to the companies’ preliminary data, "a third dose provides a similar level of neutralizing antibodies to Omicron as is observ…
COVID-19: FDA Clears Moderna, Pfizer Boosters For All US Adults COVID-19: FDA Clears Moderna, Pfizer Boosters For All US Adults
Covid-19: FDA Clears Moderna, Pfizer Boosters For All US Adults Federal health officials have given the green light for all Americans to get COVID-19 booster shots for all adults. The Food and Drug Administration (FDA) authorized Moderna and Pfizer COVID-19 booster shots for all adults in the US 18 and older, paving the way for expanding the eligibility of boosters in advance of the holiday season. Previously, the FDA had only authorized booster shots for Americans 65 and older, and those who were at a high risk of contracting COVID-19 due to pre-existing conditions of their job. “Authorizing the use of a single booster dose of either the Moderna or Pf…
COVID-19: Pfizer Expected To Seek Approval For Boosters For All Adults COVID-19: Pfizer Expected To Seek Approval For Boosters For All Adults
Covid-19: Pfizer Expected To Seek Approval For Boosters For All Adults Pfizer and European partner BioNTech are expected to seek federal authorization to administer its COVID-19 booster shot to all Americans over the age of 18. As soon as this week, the biopharmaceutical company is reportedly planning to seek US Food and Drug Administration (FDA) approval for booster shots for anyone 18 and older. Currently, only Americans 65 and older, those who are immunocompromised and anyone whose job puts them at a larger risk for exposure are eligible for Pfizer booster shots. The FDA is considered likely to grant the request, potentially before Thanksgiving and the hol…
COVID-19: Here's When General Public Likely Will Need To Get Boosters, Dr. Fauci Says COVID-19: Here's When General Public Likely Will Need To Get Boosters, Dr. Fauci Says
Covid-19: Here's When General Public Likely Will Need To Get Boosters, Dr. Fauci Says COVID-19 booster shots could soon be made available to all Americans. Dr. Anthony Fauci, one of the country’s foremost authorities on infectious diseases, said this week that Pfizer and Moderna boosters could be coming for all, not just certain groups that are currently eligible. Currently, Americans who are over the age of 65, those who are immunocompromised, and anyone who is frequently exposed to the virus through work is eligible for the COVID-19 booster shots six months after receiving their second dose. According to Fauci, it is expected that everyone will eventually need booster sh…
COVID-19: Immunocompromised People May Need Fourth Dose, CDC Says COVID-19: Immunocompromised People May Need Fourth Dose, CDC Says
Covid-19: Immunocompromised People May Need Fourth Dose, CDC Says Some Americans may require a fourth shot of the COVID-19 vaccine if they are immunocompromised, according to new federal guidance. The Centers for Disease Control and Prevention (CDC), said that adults 18 and older who received the Pfizer or Moderna COVID-19 vaccines and are moderately or severely immunocompromised may get a fourth dose at least six months after getting their third shot, the guidance states. Officials cautioned that Johnson & Johnson recipients “should not receive more than two COVID-19 vaccine doses,” though a second is recommended. The CDC authorized a thir…
COVID-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans COVID-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans
Covid-19: FDA Authorizes Moderna, J&J Booster Shots For Millions Of Americans The Food and Drug Administration has authorized the use of Johnson & Johnson and Moderna COVID-19 booster shots for millions of people across the United States. The FDA made the announcement on Wednesday afternoon, Oct. 20, nearly a month after the agency authorized the use of a Pfizer COVID-19 booster shot.  The agency said a single booster dose of the Moderna vaccine can be administered at least six months after the two-dose vaccine series is complete in the following groups of people: 65 years of age and older 18 through 64 years of age at high risk of severe COVID-19 18 …
COVID-19: Johnson & Johnson To Seek Authorization For Booster Shot COVID-19: Johnson & Johnson To Seek Authorization For Booster Shot
Covid-19: Johnson & Johnson To Seek Authorization For Booster Shot Johnson & Johnson is seeking federal approval for its COVID-19 booster shots, which could make it the latest to be authorized by the US Food and Drug Administration (FDA). On Monday, Oct. 4, a spokesperson for the pharmaceutical company announced that they were looking to gain approval to begin administering booster shots for its one-dose vaccine. Last month, regulators authorized a booster shot for some recipients of the Pfizer vaccine and are considering authorization this month for recipients of the Moderna vaccine. In total, according to reports, more than 15 million Am…
COVID-19: CT Lawmakers Approve Extension Of Lamont's Emergency Powers COVID-19: CT Lawmakers Approve Extension Of Lamont's Emergency Powers
Covid-19: CT Lawmakers Approve Extension Of Lamont's Emergency Powers Lawmakers in Connecticut have voted to extend Gov. Ned Lamont’s emergency powers through early next year. The House voted 80 to 60 to extend Lamont's powers, while the Senate voted 18 to 15 on Tuesday, Sept. 28 with three absent to approve the measure. Lamont’s powers, which were put in place at the peak of the pandemic last March, were set to expire on Thursday, Sept. 30 before the lawmakers approved the extension. Earlier story - COVID-19: Here's How Much Longer Lamont Wants Executive Powers Extended Connecticut statutes require the state legislature to approve renewing his executive po…
COVID-19: FDA Panel Recommends Booster Shots For Some Americans COVID-19: FDA Panel Recommends Booster Shots For Some Americans
Covid-19: FDA Panel Recommends Booster Shots For Some Americans COVID-19 vaccination booster shots are now being recommended for some Americans, but not others, a federal advisory group just announced. The Food and Drug Administration's scientific advisory committee held daylong discussions on Friday, Sept. 17 after which it determined that those who are age 65 or older or are at high risk of severe COVID should get booster shots. Earlier, the panel announced it had overwhelmingly voted against approving a Pfizer/BioNTech booster for all people 16 and older. The vote was 16-2. The FDA typically follows the determinations of the panel. A group of …
COVID-19: Here's How Much Longer Lamont Wants Executive Powers Extended COVID-19: Here's How Much Longer Lamont Wants Executive Powers Extended
Covid-19: Here's How Much Longer Lamont Wants Executive Powers Extended Connecticut Gov. Ned Lamont said that he expects to extend his emergency powers for another 90 days as he works with state lawmakers on certain COVID-19 mandates and protocols. With his emergency powers to expire on Thursday, Sept. 30, Lamont said he plans to extend his emergency powers 90 days further, saying that action through the General Assembly “takes too long.” The emergency powers would then be extended through Wednesday, Dec. 29. Lamont previously said that in order to continue issuing COVID-19-related executive orders, he would have to extend his emergency powers past Sept. 30. …
COVID-19: CT Has Plan In Place For Booster Shots, Lamont Says COVID-19: CT Has Plan In Place For Booster Shots, Lamont Says
Covid-19: CT Has Plan In Place For Booster Shots, Lamont Says Connecticut is ready to begin administering COVID-19 booster shots to residents across the state when they become eligible next month, Gov. Ned Lamont announced. This week, federal health officials announced that beginning the week of Monday, Sept. 20, third booster COVID-19 vaccine shots will be available to the public, citing concerns that the efficacy of Pfizer and Moderna vaccinations wanes after approximately eight months. Earlier story - COVID-19: CDC Announces Starting Date For Booster Shots In response, Lamont proclaimed that Connecticut - which had one of the most effective initia…
COVID-19: CDC Announces Starting Date For Booster Shots COVID-19: CDC Announces Starting Date For Booster Shots
Covid-19: CDC Announces Starting Date For Booster Shots Federal health officials have set a date for when they plan to begin rolling out COVID-19 booster shots to help curtail the spread of new variants of the virus. Citing new data that showed Pfizer and Moderna vaccines’ effectiveness wanes over time, President Joe Biden’s administration announced that beginning the week of Monday, Sept. 20, booster shots would be made available for many Americans. Earlier story - COVID-19: US Expected To Announce Time Frame For All Americans To Get Booster Shots The Centers for Disease Control and Prevention (CDC) and US Food and Drug Administration (FDA) sa…
COVID-19: New Study Reveals How Long Protection From Pfizer, Moderna Vaccines Could Last COVID-19: New Study Reveals How Long Protection From Pfizer, Moderna Vaccines Could Last
Covid-19: New Study Reveals How Long Protection From Pfizer, Moderna Vaccines Could Last Claims that booster shots could be required in several months for those receiving the Moderna and Pfizer COVID-19 vaccine may have been overblown, according to new reports. New findings in a study published this week showed that both COVID-19 vaccines have shown a “persistent” immune response to the virus that could potentially last years. The last looming question is how effective the vaccines are against variants of the virus, specifically the more transmissible Delta strain that has become dominant in the US and is present in 49 states. Related story - COVID-19: Parts Of US With Low Va…
COVID-19: New Studies Shed Light On Immunity For Those Who Were Vaccinated Or Had Virus COVID-19: New Studies Shed Light On Immunity For Those Who Were Vaccinated Or Had Virus
Covid-19: New Studies Shed Light On Immunity For Those Who Were Vaccinated Or Had Virus Brand-new studies are shedding light on how long immunity to COVID-19 lasts for those who have had the virus, been fully vaccinated, or both. Most who were infected with COVID and later immunized will not need booster shots, the studies show. Those who were vaccinated after never having the virus will likely need a booster shot as will some people who had COVID but did not have a strong immune response. One of the studies was published this week in the journal Nature. The other study was posted on the biology research site BioRxiv. Many who have been infected with COVID will likely make …
COVID-19: Pfizer, Moderna Release Clinical Trial Results On Response Against Virus Variants COVID-19: Pfizer, Moderna Release Clinical Trial Results On Response Against Virus Variants
Covid-19: Pfizer, Moderna Release Clinical Trial Results On Response Against Virus Variants Both Pfizer and Moderna - two of the three COVID-19 vaccines approved for distribution in the US - have seen promising results in combating variants of the virus in recent studies. This week, both pharmaceutical companies released results of clinical trials that show the vaccines are effective in combating COVID-19 variants, including the prominent strains from South Africa and Brazil. Moderna has been testing a 50-microgram dose of its vaccine in previously vaccinated people, which found the booster dose increased neutralizing antibody responses against the original virus as well as the va…